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Abstract
Background: Using blood lactate monitoring for risk assessment in the critically ill patient remains controversial.
Some of the discrepancy is due to uncertainty regarding the appropriate reference interval, and whether to
perform a single lactate measurement as a screening method at admission to the hospital, or serial lactate
measurements. Furthermore there is no consensus whether the sample should be drawn from arterial, peripheral
venous, or capillary blood. The aim of this review was:
1) To examine whether blood lactate levels are predictive for in-hospital mortality in patients in the acute setting, i.
e. patients assessed pre-hospitally, in the trauma centre, emergency department, or intensive care unit.
2) To examine the agreement between arterial, peripheral venous, and capillary blood lactate levels in patients in
the acute setting.
Methods: We performed a systematic search using PubMed, Cochrane Central Register of Controlled Trials,
Cochrane Database of Systematic Reviews, and CINAHL up to April 2011. 66 articles were considered potentially
relevant and evaluated in full text, of these ultimately 33 articles were selected.
Results and Conclusion: The literature reviewed supported blood lactate monitoring as being useful for risk
assessment in patients admitted acutely to hospital, and especially the trend, achieved by serial lactate sampling, is
valuable in predicting in-hospital mortality. All patients with a lactate at admission above 2.5 mM should be closely
monitored for signs of deterioration, but patients with even lower lactate levels should be considered for serial
lactate monitoring. The correlation between lactate levels in arterial and venous blood was found to be acceptable,
and venous sampling should therefore be encouraged, as the risk and inconvenience for this procedure is minimal
for the patient. The relevance of lactate guided therapy has to be supported by more studies.
Keywords: Lactate, triage, mortality, trauma, emergency department, intensive care unit, point-of-care
Introduction
Handheld point-of-care testing (POCT) has made it pos-
sible to assess blood lactate easy and fast, but the use of
blood lactate monitoring for risk assessment in the criti-
cally ill patient remains controversial. In the intensive
care unit (ICU), blood lactate monitoring is widely used
as an indirect marker of tissue hypoxia [1,2]. In the
assessment of the traumatized patient [3] and the criti-
cally ill patient admitted to Emergency Department (ED)
[2,4], some hospitals also include blood lactate monitor-
ing. The different policies between hospitals and depart-
ments reflect the controversy regarding the usefulness of
t h eb l o o ds a m p l e .S o m eo ft h ed i s c r e p a n c yi sd u et o
uncertainty regarding the appropriate reference interval,
and whether to perform a single lactate measurement as
a screening method at admission to the hospital, or
serial lactate measurements. Furthermore there is some
d i s c r e p a n c yw h e t h e rt h es a m p l es h o u l db eo b t a i n e d
from arterial, central venous, peripheral venous, or
capillary blood. Previous reviews do not address the
question of single versus serial sampling, cut off levels,
or point of sampling [1,5-8].
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literature to uncover whether elevated blood lactate
levels are predictive for in-hospital mortality in patients
in the acute setting, i.e. patients assessed pre-hospitally,
in the trauma center, ED, or ICU. Furthermore to exam-
ine the agreement between arterial, peripheral venous,
and capillary lactate levels in patients in the acute
setting.
Biochemistry
The blood lactate concentration reflects a balance
between production and uptake of lactate in tissues, and
is normally between 0.5-1.8 mM. Lactate is formed by
reduction of pyruvate, and is metabolized by oxidation
to pyruvate in the reaction catalyzed by the cytosolic
NAD-dependent lactate dehydrogenase (Figure 1). The
metabolic fate of pyruvate is mainly mitochondrial oxi-
dation to carbon dioxide and water with accompanying
energy production in the respiratory chain. The latter
sequence of reactions are oxygen requiring, and with
insufficient oxygen supply, or if pyruvate production for
other reasons exceeds the capacity of oxidative metabo-
lism, pyruvate will be diverted to lactate. This assures
regeneration of NAD
+ from NADH, which will enable
glycolysis, and the accompanying ATP production to
proceed. Due to the central role of the NAD-redox state
for lactate production and metabolism, any metabolic
condition giving rise to a steady-state increase in the
cytosolic NADH/NAD
+ ratio, will cause an increased
net lactate production. This applies not only to condi-
tions of hypoxia/anoxia in all tissues, but is also
observed e.g. during extensive muscular work, and dur-
ing alcohol metabolism by the liver. Lactate is released
from tissues accompanied by a proton, and because lac-
tic acid is fully dissociated at pH above approximately 6,
excessive lactate production may thus give rise to lactic
acidosis. The uptake of lactate from plasma takes place
predominantly in liver and heart, where lactate will be
used as an energy producing substrate or, in case of the
liver, as a precursor for glucose formation.
Methods
Eligibility criteria
Due to the lack of studies of high quality, it was a priori
decided to allow the inclusion of all study types. Rando-
mized, controlled trials were prioritized, but also non-
randomized trials, cohort studies, and case-control stu-
dies were considered. Case studies, studies with fewer
than 40 patients, and abstracts where full text articles
were not available were excluded. This review was
restricted to English language publications. Study char-
acteristics were defined according to PICO:
Participants: patients in the a c u t es e t t i n g ,i . e .p a t i e n t s
assessed pre-hospitally, in t h et r a u m ac e n t r e ,E D ,o r
ICU.
Intervention/exposure: elevated lactate levels in
venous, arterial or capillary blood.
Comparisons: patients with lactate within the normal
range. Outcome: in-hospital mortality.
Inclusion and exclusion criteria are listed in Table 1.
Data sources
Studies were identified by a systematic search using
PubMed, Cochrane Central Register of Controlled
Trials, Cochrane Database of Systematic Reviews, and
CINAHL up to April 2011. Reference lists of relevant
peer-reviewed literature were hand searched to identify
Figure 1 Outline of lactate metabolism. With insufficient oxygen
supply, pyruvate will be diverted to lactate, thereby assuring
regeneration of NAD
+ from NADH. This will enable glycolysis, and
the accompanying ATP production to proceed.
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
∙ Blood lactate assessment in the acute
setting: pre-hospital, emergency
department, trauma centre, or intensive
care unit
∙ Abstract only
∙ Any age ∙ Case study
∙ Single or serial lactate measured in
arterial, venous, or capillary blood
∙ Fewer than 40 patients
included
∙ Outcome measure: in-hospital mortality ∙ Based on specific types of
post-operative patients
∙ Written in English
∙ Human studies
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the electronic search.
Search strategy
We searched PUBMED systematically using the Medical
Subject Headings (MeSH),
("Lactic Acid/blood"[Mesh] OR “Lactic Acid/diagnos-
tic use"[Mesh] OR “Acidosis, Lactic/blood"[Mesh] OR
“Acidosis, Lactic/classification"[Mesh] OR “Acidosis,
Lactic/complications"[Mesh] OR “Acidosis, Lactic/diag-
nosis"[Mesh] OR “Acidosis, Lactic/drug therapy"[Mesh]
OR “Acidosis, Lactic/etiology"[Mesh] OR “Acidosis,
Lactic/metabolism"[Mesh] OR “Acidosis, Lactic/
mortality"[Mesh] OR “Acidosis, Lactic/physiopatholo-
gy"[Mesh] OR “Acidosis, Lactic/prevention and con-
trol"[Mesh] OR “Acidosis, Lactic/surgery"[Mesh]) AND
("triage"[Mesh] OR “Injury Severity Score"[Mesh] OR
“Mortality"[Mesh] OR “Blood Component Transfusion"
[Mesh] OR “Emergency medical services"[Mesh] OR
“Emergency Service, Hospital"[Mesh] OR “Sepsis"[Mesh]
OR “Point-of-care systems"[Mesh] OR “Intensive care
units"[Mesh] OR “Intensive care"[Mesh] OR “Length of
stay"[Mesh] OR “Early diagnosis"[Mesh] OR “Critical ill-
ness"[Mesh] OR “Shock"[Mesh] OR “Treatment Outco-
me"[Mesh] OR “Veins"[Mesh] OR “Arteries"[Mesh] OR
“Capillaries"[Mesh])
Study selection and data extraction
Two experts independently screened the selected studies
for inclusion. Studies were included only if both experts
considered the study as relevant for answering the study
objectives.
Information was extracted from each included study
on (1) characteristics of participants; (2) characteris-
tics of blood lactate assessment; (3) lactate cut off
value; (4) type of outcome measure; (5) statistics sup-
porting the main findings of the study. To assess the
quality of the included studies, methods validated for
internal validity, precision, and applicability (external
validity) were applied [9]. The methodological quality
and clinical relevance of each study was graded as
high, moderate, or low. The review was presented
according to ‘Preferred Reporting Items for Systema-
tic Reviews and Meta-Analysis: ‘The PRISMA state-
ment’ [10].
Results
The initial search identified 1.677 abstracts, which were
evaluated for relevance. 66 articles were considered
potentially relevant and evaluated in full text. Ultimately
33 articles were selected.
The flow diagram in Figure 2 illustrates the study
selection.
The articles that were ultimately selected were divided
in 2 groups; each group referring to one of the two
research questions. The groups were:
1) Studies investigating single or serial blood lactate
assessment (Table 2).
2) Studies comparing arterial, venous and capillary lac-
tate (Table 3).
Single blood lactate assessment
The predictive value of a single elevated blood lactate on
mortality is demonstrated in a number of studies in
patients admitted to ICU [11-16]. Four of these studies
were of moderate quality and two were of low quality.
Admission lactate ≥ 2 mM was a significant independent
predictor of mortality in adult patients admitted to ICU
in a large retrospective study by Khosravani et al. [11].
Odds Ratio (OR) for mortality increased form 1.94 to
10.89 dependent on the level of hyperlactatemia, com-
pared to patient with admission lactate < 2 mM. Studies
by Nichol et al. and Smith et al. also demonstrated a
highly significant effect of an elevated admission lactate
above 2.0 mM respectively 1.5 mM on mortality in
unselected ICU patients [12,13]. In patients admitted
acutely to ED or trauma centre several studies have
demonstrated a significant effect of elevated admission
Total citations identified by 
search strategy. N=1677 
Excluded based on the 
title/abstract. N=1611 
Full-text articles assessed for 
eligibility. N=66 
Excluded following full text review. 
N=33 
 
Reason:   N 
 
Abstract only      8 
Review article    6 
Commentary article  9 
Specific postoperative  2 
Less than 40 patients included  7 
D-lactate   1 
Studies included in qualitative synthesis. 
N=33 
        
Study type:        N 
 
Randomized, controlled studies     2 
Other interventional studies       1 
Prospective, observational studies  19 
Retrospective studies      11 
Figure 2 Flow diagram. Results of literature search and selection
process.
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Page 3 of 12Table 2 Studies investigating predictive value of single or serial blood lactate assessment.
Author,
year,
reference
Study design, study quality* N Patient characteristics Lactate
characteristics
Outcome
measure
Cut off
[mM]
Main findings
Shapiro et
al., 2005 [2]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
1278 ED patients with infection-
related diagnosis
(≥ 18 years).
Venous lactate at
admission to ED.
3-day and 28-day
in-hospital
mortality.
0-2.5; 2.5-4.0; > 4.0 Mortality rate increased with lactate levels:
0-2.5 mM: 4.9%; 2.5-4.0 mM: 9%; > 4.0 mM:
28%. Area under ROC curve for 3-day
mortality was 0.80; for 28-day mortality it
was 0.67. For 28-day mortality lactate
between 2.5-4.0 mM had sens. 59% and
spec. 71%. Lactate > 4.0 mM had sens. 36%
and spec. 92%. For 3-day mortality lactate
between 2.5-4.0 mM had sens. 76% and
spec. 71%. Lactate > 4.0 mM had sens. 55%
and spec. 91%.
Callaway et
al., 2009 [3]
Retrospective
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
588 Normotensive blunt trauma
patients
(≥ 65 years).
Venous lactate at
admission to ED.
In-hospital
mortality.
2.5 Compared to patients with admission
lactate < 2.5 mM, lactate > 4.0 mM had OR
4.2 (2.4-7.5) for death. Area under ROC curve
was 0.60.
Howell et al.,
2007 [4]
Prospective, observational
Moderate
Acceptable external validity.
Good internal validity.
Sample size of uncertain
adequacy.
1287 ED patients with infection-
related diagnosis.
Venous lactate at
admission to ED.
28-day in-hospital
mortality.
2.5-4.0; > 4.0 Admission lactate predicted 28-day mortality
independently of blood pressure (p <
0.0001). Compared to lactate < 2.5 mM,
lactate between 2.5-4.0 mM had OR 2.2 (1.1-
4.2). Lactate > 4.0 mM had OR 7.1 (3.6-13.9).
Area under ROC curve was 0.87.
Khosravani
et al., 2009
[11]
Retrospective
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
9036 Intensive care patients,
unspecified
(≥ 18 years).
Arterial or venous
lactate at admission
to ICU.
ICU mortality. 2.0 Lactate was an independent predictor of
mortality:
2-5 mM: OR 1.94 (1.62-2.32); 5-10 mM: OR
3.38 (2.64-4.33); 10-15 mM: OR 4.41 (2.99-
6.5); 15-20 mM: OR 7.58 (3.93-14.6); 20-max:
OR 10.89 (4.85-24.48). All compared to
control group with lactate < 2 mM
Nichol et al.,
2010 [12]
Retrospective
Moderate
Acceptable external validity.
Good internal validity.
Sample size of uncertain
adequacy.
7155 Intensive care patients,
unspecified.
Arterial lactate at
admission to ICU.
Serial: interval
unspecified.
In-hospital
mortality.
2.0 Compared to lactate < 0.75 mM, admission
lactate > 2.0 mM had OR for mortality at 2.1
(1.3-3.5, p = 0.01).
Sustained lactate between 0.75-1.0 mM had
OR = 2.0 (p < 0.0001). Sustained lactate >
2.0 mM had OR = 3.7 (1.9-7.0, p < 0.0001).
Smith et al.,
2001[13]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
148 Intensive care patients,
unspecified.
Arterial lactate at
admission to ICU.
Serial: 24 hours later.
28-day in-hospital
mortality.
1.5 Admission lactate > 1.5 mM was associated
with 28-day mortality (p < 0.0001). Area
under ROC curve = 0.78.
Patients with lactate > 1.0 mM at 24 hours
have significantly higher mortality (p =
0.0001).
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2Table 2 Studies investigating predictive value of single or serial blood lactate assessment. (Continued)
Suistomaa et
al., 2000 [14]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
98 Intensive care patients,
unspecified.
Arterial lactate at
admission to ICU.
Serial: every 2 hours
the first 24 hours.
In-hospital
mortality.
2.0 Median peak lactate for non-survivors was
5.3 mM (IQR, 1.9-7.5) vs. 1.9 mM (IQR, 1.3-
2.9) for survivors, p = 0.003. Hyperlactatemia
at admission to ICU was associated with
higher mortality than hyperlactatemia that
developed after admission (29.0% vs. 5.9%, p
= 0.003).
Persistent hyperlactatemia (> 6 hours) was
associated with higher mortality than
transient hyperlactatemia (36.8% vs. 0%, p =
0.008).
Hatherill et
al., 2000 [15]
Prospective, observational
Low
Acceptable external validity.
Uncertain internal validity.
Probably underpowered study.
50 Children at ICU with shock, and
initial hyperlactatemia.
Arterial lactate at
admission to ICU.
Serial: at 24 hours,
and additionally at
unspecified intervals.
ICU mortality. 2.0 The area under the ROC curve for all values
of lactate > 2 mM on admission was 0.59.
Persistent hyperlactataemia > 2 mM after 24
hours was associated with 93% mortality, as
compared to 30% in those children whose
lactate level had normalised. Persistent
hyperlactataemia at 24 hours identified
mortality with a likelihood ratio of 7, sens.
78%, and spec. 89%. The area under the
ROC curve for lactate > 2 mM at 24 h after
admission was 0.86.
Cerovic et
al., 2003 [16]
Prospective, observational
Low
Acceptable external validity.
Good internal validity.
Probably underpowered study.
94 Seriously injured patients
defined as ISS ≥ 16 who
survived ≥ 12 hours.
Arterial lactate at
admission to ICU.
Serial: every 12 hours
during the first 48
hours after admission.
In-hospital
mortality.
2.0 Admission lactate was not a significant
predictor for mortality.
Survivors exhibited a progressive decline in
lactate levels, while lactate in the non-
survivors remained broadly unchanged from
the 12th hour after the first sampling.
del Portal et
al., 2010 [17]
Retrospective
Moderate
Acceptable external validity.
Good internal validity.
Sample size of uncertain
adequacy.
1442 ED patients
(≥ 65 years).
Lactate at admission
to ED.
30-day and 60-
day in-hospital
mortality.
2.0 Admission lactate were linearly associated
with mortality (RR = 1.9 to 3.9) depending
on lactate levels (p < 0.01).
Jansen et al.,
2008 [18]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
124 Patients who required urgent
ambulance dispatching with
systolic blood pressure < 100
mmHg, or respiration rate < 10,
or > 29, or GCS < 14.
Pre-hospital venous or
capillary lactate arrival
on the site of injury
and at admission to
the hospital.
In-hospital
mortality.
3.5 Mortality was significantly higher in patients
with lactate ≥ 3.5 mM at the site of injury
(41% vs. 12%; p < 0.001) or at admission to
the hospital (47% vs.15%; p < 0.001).
Lactate, on average, increased 0.1 mM in
non-survivors, whereas in survivors, it
decreased 0.6 mM (p = 0.044) Pre-hospital
lactate had better prognostic value than
vital signs alone.
Kaplan et al.,
2004 [19]
Retrospective
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
282 Trauma patients with vascular
injury (torso or extremity).
Arterial lactate at
admission to trauma
center.
28-day in-hospital
mortality.
Admission lactate could discriminate
survivors from non-survivors (3.6 mM vs.
11.1 mM, p < 0.001).
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2Table 2 Studies investigating predictive value of single or serial blood lactate assessment. (Continued)
Pal et al.,
2006 [20]
Retrospective
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
5995 Trauma patients, unspecified. Arterial lactate at
admission to trauma
center.
In-hospital
mortality.
2.0 Survivors had 3.0 mM, and non-survivors
had 5.2 mM (p < 0.0001). Sens. and spec. of
an elevated lactate was 85% and 38%,
respectively. Area under ROC curve was
0.72. PPV was 4%.
Vandromme
et al., 2010
[21]
Retrospective
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
2413 Trauma patients with systolic
blood pressure between 90 and
110 mmHg.
Capillary or venous
lactate at admission
to hospital.
Need for ≥ 6
units packed red
blood cells within
24 hours. In-
hospital mortality.
2.5 Admission lactate was a better predictor for
mortality and need for blood transfusion
than systolic blood pressure (p < 0.0001).
Lactate had area under ROC curve = 0.76
and systolic blood pressure had area under
ROC curve = 0.61, p < 0.0001.
Arnold et al.,
2009 [22]
Retrospective
Low
Acceptable external validity.
Good internal validity.
Probably underpowered study.
166 ED patients diagnosed with
severe sepsis.
(> 17 years)
Venous lactate at
admission to ED.
Serial: interval
unspecified.
In-hospital
mortality
4.0 The mean initial lactate for survivors was 4.3
mM (SD = 2.6), while non-survivors had 4.7
mM (SD = 2.8), p = 0.41.
The mean serial lactate for survivors was 2.2
mM (SD = 1.6), while non-survivors had 3.6
mM (SD = 2.8), p < 0.001.
Guyette et
al., 2011 [23]
Retrospective
Moderate
Acceptable external validity.
Good internal validity.
Sample size of uncertain
adequacy.
1168 Trauma patients transported by
air.
(≥ 18 years)
Pre-hospital venous or
capillary lactate was
measured
In-hospital
mortality
2.0 Pre-hospital lactate was median 3.8 mM
(IQR, 2.8-6.1) in those who died and median
2.3 mM (IQR, 1.3-3.4) in those who survived
to discharge, p < 0.0001.
Trzeciak et
al. 2007 [24]
Prospective, observational
Low
Acceptable external validity.
Uncertain internal validity.
Sample size of uncertain
adequacy.
1177 ED patients with diagnosis of
sepsis or infection.
(> 18 years).
Venous lactate at
admission to ED.
In-hospital
mortality and
death within 3
days from
measurement
4.0 Compared to baseline 0.0-2.0 mM, patients
with lactate ≥ 4.0 mM had OR 6.1(3.7-10.5)
for dying within 3 days from lactate
measurement. Sens. 35%. Spec. 92%. Area
under ROC curve 0.63. Equivalently lactate ≥
4.0 mM had OR 3.0(2.0-4.6) for in-hospital
death. Sens. 19%. Spec. 93%. Area under
ROC curve was 0.56.
Kaplan et al.,
2008 [25]
Retrospective
Low
Acceptable external validity.
Good internal validity.
Probably underpowered study.
78 Patients with blunt, or
penetrating trauma requiring
intensive care
Arterial lactate at
admission to ED.
28-day in-hospital
mortality.
2.2 Admission lactate could not discriminate
survivors from non-survivors (2.3 mM vs. 2.9
m, p = 0.24). Area under ROC curve was 0.6.
Van Beest et
al., 2009 [27]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
135 Patients with at least 2
symptoms of shock.
(≥ 18 years)
Pre-hospital capillary
or venous lactate.
Length of stay,
and in-hospital
mortality.
4.0 Hyperlactamic patients had significantly
higher mortality (12.2% vs. 44.3%, p = 0.002),
longer LOS at ICU (p = 0.03), and LOS in
hospital (p = 0.04). Area under ROC curve
was 0.775. Lactate > 3.2 mM was the
optimal cut off with sens. 75% and spec.
72%.
Nguyen et
al., 2004 [28]
Prospective, observational
Moderate
Acceptable external validity.
Good internal validity.
Sample size of uncertain
adequacy.
111 Patients with severe sepsis or
septic shock.
(> 18 years).
Arterial lactate at
admission to ED.
Serial: at 6 hours.
60-day in-hospital
mortality.
**
Lactate clearance less than 10% in 6 hours
was associated with a higher 60-day
mortality, than lactate clearance more than
10% (p = 0.007). Sens. 44.7% and spec.
84.4%.
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2Table 2 Studies investigating predictive value of single or serial blood lactate assessment. (Continued)
Claridge et
al., 2000 [29]
Prospective, observational
Moderate
Acceptable external validity.
Good internal validity.
Sample size of uncertain
adequacy.
381 Trauma patients requiring
intensive care.
Lactate at admission
to ED.
Serial: every 4-6 hours.
In-hospital
mortality.
2.4 **
Patients with sustained hyperlactatemia (>
12 hours) had higher risk of infection
(pneumonia etc.) than controls (69.8% vs.
40%, p < 0.001). The mortality rate for
patients who developed infection was 7.9%
vs. 1.9% (p < 0.05).
Jansen et al.,
2009 [30]
Prospective, observational
Low
Acceptable external validity.
Good internal validity.
Probably underpowered study.
394 Intensive care patients with
sepsis, hemorrhage, or other
conditions of low oxygen
transport.
Arterial lactate at
admission to ICU.
Serial: 12 and 24
hours after admission.
In-hospital
mortality.
2.5 **
Reduction of lactate within 24 hours was
associated with significantly lower mortality
in the septic group (p = 0.003), but not in
the other groups, (p = 0.42).
Kliegel et al.,
2004 [31]
Retrospective
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
394 Patients resuscitated after
cardiac arrest who survived >
48 hours.
Arterial lactate. First
sample at admission
to ED.
Serial: every 4-8 hours.
In- hospital
mortality.
2.0 On admission survivors had 7.8 mM (IQR,
5.4-10.8) and non-survivors had 9 mM (IQR,
6.5-11.9), p < 0.01.
Lactate > 2 mM after 48 hours predicted
mortality with a spec. of 86%, and poor
neurologic outcome with a spec. of 87%.
Sens. for both were 31%.
Jansen et al.,
2010 [32]
Randomised, controlled trial
High
Acceptable external validity.
Good internal validity.
Premeditated and sufficient
study size.
348 Intensive care patients,
unspecified.
(≥ 18 years).
Arterial lactate at
admission to ICU.
(venous and capillary
lactate was also
allowed).
Serial: every 2 hours.
In-hospital
mortality.
3.0 **
Hazard ratio in the intervention group was
0.61 (0.43-0.87, p = 0.006). Reduction of
lactate below 2.0 mM was not associated
with better outcome.
Jones et al.,
2010 [33]
Randomised, controlled trial
High
Acceptable external validity.
Good internal validity.
Premeditated and sufficient
study size.
300 Patients with severe sepsis and
hypoperfusion or septic shock.
(≥ 17 years).
Venous lactate at
admission to ICU.
Serial: every hour.
In-hospital
mortality.
2.0 **
No difference in mortality was observed in
patients treated by a protocol aiming at
normalizing blood lactate compared to
normalizing SvO2.
Blow et al.,
1999 [43]
Prospective, intervention
Low
Acceptable external validity.
Uncertain internal validity.
Probably underpowered study.
79 Hemo-dynamic stable trauma
patients with ISS ≥ 20 and
survival > 24 hours.
Lactate at admission
to trauma centre.
Serial: interval
unspecified.
In-hospital
mortality.
2.5 **
Persistent hyperlactatemia after 24 hours
was associated with increased mortality (p <
0.05).
Lee et al.,
2008 [44]
Prospective, observational
Low
Acceptable external validity.
Good internal validity.
Probably underpowered study.
126 Patients with severe sepsis, or
septic shock.
(≥ 20 years).
Arterial lactate at
admission to ED.
Serial: 4 hours later.
In-hospital
mortality.
2.0 **
No significant difference in mortality was
found between patients with elevated
lactate compared to normal lactate, as long
as pH was within normal limits.
Numbers in brackets are 95% confidence interval unless specified otherwise. *quality rated by using methods validated for internal validity, precision, and applicability (external validity) [9]. **Predictive value of
admission lactate in relation to mortality not commented. ED = emergency department; ROC = receiver operating characteristic; sens. = sensitivity; spec. = specificity; OR = odds ratio; ICU = intensive care unit; IQR =
interquartile range; ISS = injury severity score; RR = relative risk; GCS = Glascow coma scale; PPV = positive predictive value; SD = standard deviation; LOS = length of stay; SvO2 = central venous oxygen saturation.
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2Table 3 Studies with comparison of arterial, venous, and capillary lactate.
Author,
year,
reference
Study design, study quality* N Patient
characteristics
Lactate characteristics Outcome measure Cut
off
[mM]
Main findings
Lavery et
al., 2000
[26]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
231 Trauma patients,
unselected.
Arterial and peripheral venous
lactate within 10 min after
admission at trauma center.
Comparison of arterial and
venous lactate.
2.0 No significant difference between arterial and venous
lactate was found. The correlations were: a.femoralis-v.
femoralis, r = 0.95; a.femoralis-peripheral vein, r = 0.935; a.
radialis-peripheral vein, r = 0.988. No significant difference
was found for peripheral venous lactate drawn with or
without the use of tourniquet. For LOS > 2 days, lactate >
2.0 mM had sens. 68%, spec. 41%, PPV 71%, and NPV 48%.
For in-hospital mortality, lactate > 2.0 mM had sens. 95%,
spec. 43%, PPV 16%, and NPV 99%.
Boldt et
al., 2001
[34]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
40 Surgical
intensive care
patients,
unselected.
Arterial and capillary lactate at
inclusion day, after 8 hours,
and once per day the
following three days.
Compares POCT and
laboratory lactate.
Comparison of arterial and
capillary lactate.
2.0 Correlation between POCT and the hospital laboratory for
measuring lactate in arterial blood was r
2 = 0.97. Bland-
Altman showed bias 0.15 mM with POCT tending to be
lower. Correlation between capillary and arterial blood was
r
2 = 0.80. Bland-Altman showed bias 0.59 mM with capillary
lactate tending to be higher.
Perez et
al., 2008
[35]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
120 Patients in
antiretroviral
therapy with
hyperlactatemia.
Venous lactate. Compares POCT and
reference-instrument.
2.2 Correlation between mean venous lactate measured with
POCT and reference instrument (2.89 mM vs. 2.78 mM), r =
0.63. The POCT instrument had a sensitivity of 95.9%, and a
specificity of 63.8% for hyperlactatemia. PPV was 80.5%. NPV
was 90.9%. Agreement was analysed by Bland-Altman plot.
Bias was 0.113 mM (-2.103-2.329) with POCT tending to
show higher values.
Shapiro
et al.,
2010 [36]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
699 Patients with
suspected
infection
(pneumonia
etc.).
(≥ 18 years).
Venous lactate in the
emergency department.
Convenience sample.
Comparison of POCT
venous lactate and
laboratory venous control.
In-hospital mortality.
Correlation between venous lactate measured by POCT and
laboratory was 0.97. POCT lactate had area under ROC curve
= 0.72 for mortality. Bland-Altman plot showed that POCT
lactate was, on average, 0.32 mM (-0.35-0.98) lower than
laboratory lactate, with agreement kappa = 0.97.
Gallagher
et al.,
1997 [37]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
69 Emergency
department
patients (≥ 18
years).
Arterial and peripheral venous
lactate. Convenience sample.
Comparison of arterial and
peripheral venous lactate.
1.6 Correlation between arterial and peripheral venous lactate
was r
2 = 0.89. There was no correlation between the arterio-
venous difference and tourniquet time (r
2 = 0.02). Peripheral
venous lactate had a sensitivity of 94%, and a specificity of
57% for hyperlactatemia. Bias was 0.22 mM (0.04-0.41) with
venous lactate tending to be higher.
Younger
et al.,
1996 [38]
Prospective, observational
Moderate
Acceptable external validity.
Acceptable internal validity.
Sample size of uncertain
adequacy.
48 Emergency
department
adult patients.
(≥ 17 years).
Arterial and peripheral venous
lactate.
Comparison of arterial and
peripheral venous lactate.
1.6 Peripheral venous lactate > 1.6 mM has sensitivity of 100%,
and specificity of 86% for hyperlactatemia. The correlation
between arterial and venous lactate was r
2 = 0.71 (p <
0.001). Bland-Altman plot showed bias 0.18 mM (0.012-
0.372) with venous lactate tending to be higher.
Numbers in brackets are 95% confidence interval unless specified otherwise. *quality rated by using methods validated for internal validity, precision, and applicability (external validity) [9]. LOS = length of stay;
sens. = sensitivity; spec. = specificity; PPV = positive predictive value; NPV = negative predictive value; POCT = point-of-care testing; ROC = receiver operating characteristic.
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2lactate on in-hospital mortality [2-4,17-26]. Ten of these
studies were of moderate quality, and three were of low
quality. The admission lactate in this group of patients
was either assessed pre-hospitally, by admission to the
ED, or the ICU. The cut-off value was chosen between
2.0 and 4.0 mM. Two minor studies were not able to
demonstrate a significant difference between survivors
and non-survivors based on a single elevated lactate
measurement [22,25]. In addition to in-hospital mortal-
ity as the primary outcome measure, some studies also
demonstrated a significant effect on secondary outcome
measures; for instance length of hospital stay [26,27]
and the need for blood transfusion within the first 24
hours [21]. Several of the studies express a dose-
response relationship between lactate levels and mortal-
ity [2,4,11,12,17].
Serial blood lactate assessment
Sustained hyperlactatemia among ICU patients, demon-
strated by serial measurements, has shown to be predic-
tive for in-hospital mortality [12-16,28-30]. Five of these
studies were of moderate quality and three were of low
quality. In these studies, high lactate levels in serial mea-
surements and prolonged time to normalize lactate, pre-
dicted a higher mortality rate. Most studies used 2.0
m Ma sc u to f fp o i n t .I nal a r g es t u d yb yN i c h o le ta l . ,
however, sustained lactate levels as low as 0.75-1.0 mM
were associated with doubling of the risk of adverse out-
come (OR = 2.0, p < 0.0001) [12]. In 2004 Kliegel et al.
examined patients who were resuscitated from cardiac
arrest and survived at least 48 hours [31]. They con-
cluded that sustained hyperlactatemia (> 2.0 mM after
48 hours) was predictive for mortality as well as poor
neurological outcome. Only one single study has evalu-
ated the value of serial lactate monitoring pre-hospitally
[18]. In this study, Jansen et al. assessed lactate at the
site of injury and at arrival to the hospital, and found
that mortality was significantly higher in patients with
lactate > 3.5 mM at the site of injury (41% vs. 12%, p <
0.001), or at admission to the hospital (47% vs. 15%; p <
0.001) compared to patients with lactate levels < 3.5
mM. Pre-hospital lactate had better prognostic value
than vital signs such as blood pressure alone. The effect
of lactate guided treatment was studied in a randomized
controlled study of ICU patients [32]. The administra-
tion of erythrocytes, dobutamine, and fluid substitution
was administrated following an algorithm targeting a
SvO2 at 70%. In the intervention group further therapy
with vasodilators was started if lactate clearance was less
than 20% in 2 hours. When adjusted for predefined risk
factors, in-hospital mortality was significantly lower in
the intervention group (hazard ratio 0.61; 95% CI 0.43-
0.87, p = 0.006). No further reduction in mortality was
observed when lactate levels were reduced to less than 2
mM. In a randomized controlled study by Jones et al.,
septic patients and other patients with hypoperfusion
were treated by two different resuscitation protocols,
o n eg u i d e db yS v O 2 and the other guided by lactate
levels [33]. There was no significant difference in mor-
tality between the two groups.
Comparison of arterial, venous, and capillary lactate
Point-of-care testing has enabled monitoring of lactate
levels close to the patients in the general ward, in the
ambulance, or in the ED. Six studies investigating arter-
ial, venous, and capillary lactate were included. All stu-
dies were of moderate quality. High accuracy was
demonstrated in a number of studies, when lactate was
analyzed using POCT compared to laboratory results in
the same type of blood (venous, arterial, or capillary)
[34-36]. The correlation between arterial and capillary
values of lactate was evaluated in 2001 by Boldt et al.,
who showed a moderate correlation between lactate
measured in capillary blood compared to arterial values
(r
2 = 0,80) in 40 intensive care patients [34]. They
recommended that capillary lactate should not substitute
arterial lactate in critically ill patients due to the risk of
overestimating lactate levels. The correlation between
arterial and peripheral venous lactate has been investi-
gated by Lavery et al., who found no significant differ-
ence between arterial and venous levels of lactate, the
highest correlation being between the radial artery and a
peripheral vein (r = 0.988) [26]. In a study with patients
admitted to ED, Gallagher et al. found a correlation at
r
2 = 0.89 between arterial and venous lactate [37].
Venous lactate tended to be overestimated (bias 0.22
mM, 95% CI (0.04-0.41)). Younger et al. found a moder-
ate correlation between arterial and venous lactate (r
2 =
0.71) in patients admitted to ED, also with tendency of
venous lactate being overestimated (bias 0.18 mM, 95%
CI (0.012-0.372)) [38]. The sensitivity and specificity of
peripheral venous lactate for hyperlactatemia were
found to be 94% and 57% respectively in the study by
Gallagher et al., while sensitivity was 100% and specifi-
city was 86% in the study by Younger et al. [37,38]. No
difference was found in peripheral venous lactate level
when comparing sampling with or without the use of
tourniquet [26,37].
Discussion
Single versus serial lactate monitoring
Most studies reviewed here support single lactate mea-
surements, assessed at admission to the hospital, as
being useful in terms of predicting adverse outcome.
The predictive value of blood lactate is further sup-
ported by the fact that several studies demonstrate a
dose-response relationship; the higher the lactate levels,
the higher the mortality rates. The predictive value of a
Kruse et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2011, 19:74
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Page 9 of 12single lactate assessed at admission is, however, contro-
versial, as several studies were not able to show a signifi-
cant predictive value of admission lactate [16,22,25].
Furthermore there is great heterogeneity between stu-
dies when defining, at what stage an admission lactate
should be taken; some studies choosing the first patient
contact, others when the patient is admitted to ICU. In
the population admitted to ICU, close monitoring of all
patients are mandatory, and it seems reasonable to per-
form serial lactate measurement on all patients. How-
ever in trauma patients or patients admitted to ED, a
decision based on a single lactate measurement could be
useful in terms of deciding the level of observation and
treatment, and to select patients for serial lactate moni-
toring. Sustained hyperlactatemia has been shown to be
predictive for adverse outcome in a number of studies,
and therefore serial lactate measurements might be a
useful approach to monitor the critically ill patient.
Another advantage by using serial measurements is that
patients having a temporary and non-pathologically ele-
vated lactate, for instance as a result of a high adrena-
line level [39], or alcohol intake [40], are excluded from
the population. There is no agreement about the opti-
mal time interval between serial lactate sampling. Jansen
et al. aimed to reduce lactate by 20% per 2 hours, and
m a n a g e dt or e d u c em o r t a l i t ys ignificantly in the inter-
vention group [32]. Therefore, based on the reviewed
articles, an interval between two and six hours seems
reasonable to be able to follow the trend.
Lactate cut off point
This study was not designed to specify the appropriate
lactate cut off values. Setting the cut off point for lactate
in order to predict patient outcome, is a question of get-
ting the optimal relationship between sensitivity and
specificity. This is most easily visualized by the receiver
operating characteristics (ROC) [41]. A test with high
sensitivity carries the risk of many false positive and
hence over-triage. On the other hand, if the test is used
for screening purposes, or as a part of multifactorial risk
assessment, it might be desirable with a certain level of
over-triage. The higher the cut off point, the better pre-
d i c t i v ev a l u eo fap o s i t i v et e s t ,a n dt h eg r e a t e rr i s kf o r
getting false negative results. Several of the studies
demonstrating a significant predictive value of single
lactate, assessed at admission to hospital, had a cut off
point at 2.5 mM [2,4,21]. Studies which used a higher
cut off point, also found significant predictive value of
admission lactate [18,24]. When 2.0 mM was used as
cut off point, the predictive value of admission lactate
became more controversial. This indicates that the cut
off point for lactate, assessed at admission to hospital,
probably should lie in the interval 2.0-2.5 mM. The cut
off point for sustained hyperlactatemia are for several
studies 2.0 mM [12,14-16,31]. A few studies even found
significantly increased mortality for a sustained lactate
as low as 0.75-1.0 mM [12,13]. More studies are needed
to support this very low cut off point; it will inevitably
lead to the risk of over-triage. It is possible however,
that the limit for serial lactate should be considered
lower than for admission lactate.
Lactate measured in capillary, arterial, or venous blood
The golden standard in assessing lactate levels is in
arterial blood. In a previous review, the authors con-
cluded that most studies found a satisfactory agree-
ment between the capillary, peripheral venous, and
arterial lactate [1]. The studies available, however, are
all quite small, and they present conflicting conclu-
sions in relation to whether the capillary lactate could
replace the arterial, due to tendency of a higher lactate
result in capillary blood. Peripheral venous lactate
demonstrates a good correlation to the arterial lactate,
as well as a very high sensitivity and acceptable specifi-
city for hyperlactatemia. Bland-Altman plots show bias
between 0.18-0.22 mM, with the tendency of venous
lactate being higher than arterial lactate [37,38]. Set-
ting the same cut-off for arterial and venous lactate
levels will lead to more false positive results when
using venous lactate, but makes lactate in peripheral
blood a reasonable screening test, because all patients
with hyperlactatemia are found. An arterial puncture
requires training of the personnel, can be time con-
suming, expensive, and subject to pain and inconveni-
ence for the patient [26,34]. A venous or capillary
lactate would increase the accessibility of the test,
because the sample could be drawn together with
other venous blood samples at admission to hospital,
or in the ambulance. Furthermore a venous or capillary
sample carries minimal risk and inconvenience for the
patient, and minimal training of the personnel. The
use of capillary lactate carries the risk of over-triage,
unless the cut off point is set higher than for arterial
lactate.
Strengths and limitations
The strength of this review is due to the systematic
search and inclusion of studies. The quality of the stu-
dies reviewed is, however, not optimal. The majority of
the studies presented here are of moderate or low
quality, and suffers from a sample size of uncertain
adequacy; some of the studies are quite small and
probably underpowered. Furthermore convenience
samples are used in the studies comparing lactate
levels in capillary, arterial, and venous blood with the
associated risk of getting selection bias. The lactate
t a k e na ta d m i s s i o ni sn o tc l e a r l yd e f i n e d ;t h eb l o o d
sample is taken in the ED, the ICU, or pre-hospitally
Kruse et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2011, 19:74
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Page 10 of 12depending on the study design. In addition, the popu-
lation is heterogeneous and in different phases of the
acute process. We find, that an attempt to evaluate the
strength of the recommendation for monitoring lactate,
for instance using the internationally accepted GRADE
system, is not possible duet ot h eh e t e r o g e n e i t y
between studies [42]. This is in accordance with the
conclusion of Jansen et al, in a recent review discuss-
ing the use of lactate monitoring [1]
Future research
The lactate cut off values should be confirmed by larger,
prospective studies. These should be followed by inter-
ventional studies to determine if therapy directed
towards a reduction in lactate levels improve patient
outcome compared to a control group. Lactate level is a
surrogate parameter for the insufficiency of the circula-
tion. Therefore all interventions aiming at improving the
circulation (fluids, inotropes etc.) will have an effect on
lactate levels. It is probably not the elevated lactate per
se, but the underlying condition that increases the risk
for adverse outcome. This needs to be further investi-
gated. Concerning the discussion about the use of capil-
lary and peripheral lactate, a study with a larger number
of patients is wanted. The study should aim to take
arterial, peripheral venous, and capillary lactate within a
short time relative to each other, and preferably serial
measurements over time. It would be beneficial to
include a subpopulation of patients with hypotension,
since peripheral constriction, triggered by increased
sympathetic activity, could lead to artificially high lactate
values when measured on capillary blood.
Conclusions
Blood lactate monitoring is useful for risk assessment in
patients admitted acutely to hospital, and especially the
trend in serial lactate monitoring is valuable in predict-
ing in-hospital mortality. All patients with a lactate at
admission above 2.5 mM should be closely monitored
for signs of deterioration, and patients with even lower
lactate levels should be considered for serial lactate
monitoring. Peripheral venous blood lactate is highly
correlated with arterial blood lactate, and venous sam-
pling should therefore be encouraged, as the risk and
inconvenience for this procedure is minimal for the
patient. The relevance of lactate guided therapy has to
be supported by more studies.
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